cgs 25462 has been researched along with enalapril in 1 studies
| Studies (cgs 25462) | Trials (cgs 25462) | Recent Studies (post-2010) (cgs 25462) | Studies (enalapril) | Trials (enalapril) | Recent Studies (post-2010) (enalapril) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 6,311 | 1,924 | 859 |
| Protein | Taxonomy | cgs 25462 (IC50) | enalapril (IC50) |
|---|---|---|---|
| Angiotensin-converting enzyme | Homo sapiens (human) | 0.3536 | |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 2.7083 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 1.2 | |
| Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 0.14 | |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.14 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amiri, F; Gannon, P; Pu, Q; Schiffrin, EL | 1 |
1 other study(ies) available for cgs 25462 and enalapril
| Article | Year |
|---|---|
Dual angiotensin-converting enzyme/neutral endopeptidase inhibition on cardiac and renal fibrosis and inflammation in DOCA-salt hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Cell Adhesion Molecules; Collagen; Desoxycorticosterone; Drug Therapy, Combination; Enalapril; Fibrosis; Heart Diseases; Hypertension; Inflammation; Kidney Diseases; Metalloendopeptidases; Neprilysin; NF-kappa B; Organophosphonates; Pyridines; Rats; Rats, Sprague-Dawley; Thiazepines | 2005 |